A major clinical trial reveals no significant difference in 1-year DMEK graft success rates between diabetic and non-diabetic corneal donors, supporting an expanded donor pool.
Most Recent Articles
STELLAR-303 Trial: Redefining Treatment for Refractory Metastatic Colorectal Cancer
The STELLAR-303 trial shows zanzalintinib plus atezolizumab significantly improves overall survival in refractory metastatic colorectal cancer, offering a new immunotherapy-based treatment option.
Personalizing Colon Cancer Treatment: The Role of Circulating Tumor DNA
The DYNAMIC-III trial reveals how ctDNA-guided adjuvant therapy impacts recurrence-free survival and treatment toxicity in stage III colon cancer, highlighting future challenges.
Innovating Stroke Research: Integrating AI, Platform, and Pragmatic Trial Designs
Explore the opportunities and challenges of integrating artificial intelligence and novel trial designs to revolutionize acute ischemic stroke research and clinical care.
Beyond Traditional Risk Factors: VAT and Hepatic Fat’s Impact on Carotid Health
Explore how visceral adipose tissue and hepatic fat independently influence carotid atherosclerosis, beyond traditional risk factors, according to findings from major cohort studies.